SOTERA HEALTH COMPANY Goodwill, Foreign Currency Translation Gain (Loss)
SOTERA HEALTH COMPANY (SHC) reported Goodwill, Foreign Currency Translation Gain (Loss) of -$11.98 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2026-08-06
- SOTERA HEALTH COMPANY goodwill, foreign currency translation gain (loss) for the quarter ending 2026-06-30 was -$6.38M, a 131.70% decline year-over-year.
- SOTERA HEALTH COMPANY goodwill, foreign currency translation gain (loss) for the quarter ending 2026-03-31 was -$5.60M, a 269.17% decline year-over-year.
- SOTERA HEALTH COMPANY goodwill, foreign currency translation gain (loss) for the quarter ending 2025-12-31 was $40.06M.
- SOTERA HEALTH COMPANY goodwill, foreign currency translation gain (loss) for the quarter ending 2025-09-30 was -$41.33M.
- SOTERA HEALTH COMPANY goodwill, foreign currency translation gain (loss) for fiscal 2025 was $22.16M.
- SOTERA HEALTH COMPANY goodwill, foreign currency translation gain (loss) for fiscal 2024 was -$30.12M, a 419.65% decline from fiscal 2023.
- SOTERA HEALTH COMPANY goodwill, foreign currency translation gain (loss) for fiscal 2023 was $9.42M.
- SOTERA HEALTH COMPANY goodwill, foreign currency translation gain (loss) for fiscal 2022 was -$23.20M.
| Period end | Goodwill, Foreign Currency Translation Gain (Loss) 3 month | Goodwill, Foreign Currency Translation Gain (Loss) 6 month | Goodwill, Foreign Currency Translation Gain (Loss) 9 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$6.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$11.98M 10-Q · filed 2026-08-06 | $28.08M derived: sum of 3 quarters · filed 2026-08-06 | -$13.25M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$5.60M 10-Q · filed 2026-05-05 | $34.46M derived: sum of 2 quarters · filed 2026-05-05 | -$6.87M derived: sum of 3 quarters · filed 2026-05-05 | $13.25M derived: sum of 4 quarters · filed 2026-05-05 |
| 2025-12-31 | $40.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$1.27M derived: sum of 2 quarters · filed 2026-02-24 | $18.85M derived: sum of 3 quarters · filed 2026-02-24 | $22.16M 10-K · filed 2026-02-24 |
| 2025-09-30 | -$41.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$21.21M derived: sum of 2 quarters · filed 2025-11-04 | -$17.90M 10-Q · filed 2025-11-04 | -$54.65M derived: sum of 4 quarters · filed 2026-02-24 |
| 2025-06-30 | $20.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $23.43M 10-Q · filed 2025-08-08 | -$13.32M derived: sum of 3 quarters · filed 2026-02-24 | -$19.57M derived: sum of 4 quarters · filed 2026-02-24 |
| 2025-03-31 | $3.31M 10-Q · filed 2025-05-01 | -$33.44M derived: sum of 2 quarters · filed 2026-02-24 | -$39.69M derived: sum of 3 quarters · filed 2026-02-24 | -$18.47M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-12-31 | -$36.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$43.00M derived: sum of 2 quarters · filed 2026-02-24 | -$21.78M derived: sum of 3 quarters · filed 2026-02-24 | -$30.12M 10-K · filed 2026-02-24 |
| 2024-09-30 | -$6.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $14.97M derived: sum of 2 quarters · filed 2024-11-05 | $6.63M 10-Q · filed 2024-11-05 | $17.01M derived: sum of 4 quarters · filed 2025-02-27 |
| 2024-06-30 | $21.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $12.88M 10-Q · filed 2024-08-05 | $23.26M derived: sum of 3 quarters · filed 2025-02-27 | $31.04M derived: sum of 4 quarters · filed 2025-02-27 |
| 2024-03-31 | -$8.34M 10-Q · filed 2024-05-02 | $2.04M derived: sum of 2 quarters · filed 2025-02-27 | $9.81M derived: sum of 3 quarters · filed 2025-02-27 | -$569.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-12-31 | $10.38M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $18.15M derived: sum of 2 quarters · filed 2025-02-27 | $7.77M derived: sum of 3 quarters · filed 2025-02-27 | $9.42M 10-K · filed 2025-02-27 |
| 2023-09-30 | $7.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$2.61M derived: sum of 2 quarters · filed 2023-11-01 | -$957.00K 10-Q · filed 2023-11-01 | $8.34M derived: sum of 4 quarters · filed 2024-02-27 |
| 2023-06-30 | -$10.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$8.73M 10-Q · filed 2023-08-03 | $569.00K derived: sum of 3 quarters · filed 2024-02-27 | -$40.85M derived: sum of 4 quarters · filed 2024-02-27 |
| 2023-03-31 | $1.65M 10-Q · filed 2023-05-03 | $10.95M derived: sum of 2 quarters · filed 2024-02-27 | -$30.46M derived: sum of 3 quarters · filed 2024-02-27 | -$27.00M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-12-31 | $9.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$32.12M derived: sum of 2 quarters · filed 2024-02-27 | -$28.65M derived: sum of 3 quarters · filed 2024-02-27 | -$23.20M 10-K · filed 2024-02-27 |
| 2022-09-30 | -$41.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$37.95M derived: sum of 2 quarters · filed 2022-11-02 | -$32.50M 10-Q · filed 2022-11-02 | -$33.74M derived: sum of 4 quarters · filed 2023-02-28 |
| 2022-06-30 | $3.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $8.92M 10-Q · filed 2022-08-04 | $7.67M derived: sum of 3 quarters · filed 2023-02-28 | -$3.19M derived: sum of 4 quarters · filed 2023-02-28 |
| 2022-03-31 | $5.45M 10-Q · filed 2022-05-05 | $4.21M derived: sum of 2 quarters · filed 2023-02-28 | -$6.66M derived: sum of 3 quarters · filed 2023-02-28 | $792.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-12-31 | -$1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$12.11M derived: sum of 2 quarters · filed 2023-02-28 | -$4.66M derived: sum of 3 quarters · filed 2023-02-28 | -$5.16M 10-K · filed 2023-02-28 |
| 2021-09-30 | -$10.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$3.41M derived: sum of 2 quarters · filed 2021-11-10 | -$3.91M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $7.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $6.95M 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | -$501.00K 10-Q · filed 2021-05-13 | |||
| 2020-12-31 | $11.03M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |